Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 74 (2024): Issue 1 (March 2024)
Open Access
Furanocoumarin compounds isolated from
Dorstenia foetida
potentiate irinotecan anticancer activity against colorectal cancer cells
Supusson Pengnam
Supusson Pengnam
,
Watcharapa Jitkaroon
Watcharapa Jitkaroon
,
Roongtiwa Srisuphan
Roongtiwa Srisuphan
,
Pawaris Wongprayoon
Pawaris Wongprayoon
,
Kanok-On Rayanil
Kanok-On Rayanil
and
Purin Charoensuksai
Purin Charoensuksai
| Mar 30, 2024
Acta Pharmaceutica
Volume 74 (2024): Issue 1 (March 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Mar 30, 2024
Page range:
61 - 79
Accepted:
Oct 03, 2023
DOI:
https://doi.org/10.2478/acph-2024-0004
Keywords
5-methoxy-3-(3-methyl-2,3-dihydroxybutyl)-psoralen diacetate
,
furanocoumarins
,
anticancer activity
,
irinotecan
,
synergism
© 2024 Supusson Pengnam et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.